Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. - Wikidata - awgldk - TriplyDB

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

http://www.wikidata.org/entity/Q47776871

about

The role of osteoprotegerin in arthritis A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies Promising bone-related therapeutic targets for rheumatoid arthritis.Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation.Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort.RANK, RANKL and osteoprotegerin in arthritic bone loss.Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis.IKK{beta} as a target for treatment of inflammation induced bone loss.Rheumatic diseases: the effects of inflammation on bone.CD44 is a determinant of inflammatory bone loss.Mechanisms of Disease: the link between RANKL and arthritic bone disease.RANK ligand inhibition with denosumab for the management of osteoporosis.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Genetic confirmation for a central role for TNFα in the direct action of thyroid stimulating hormone on the skeleton Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement Lymphocyte-derived cytokines in inflammatory arthritis.Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.Denosumab: an investigational drug for the management of postmenopausal osteoporosis Inflammation, cancer, and bone loss.Conjugated linoleic Acid prevents ovariectomy-induced bone loss in mice by modulating both osteoclastogenesis and osteoblastogenesis.Osteoporosis in inflammatory joint diseases.Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.Skeletal and extraskeletal actions of denosumab.Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.Can bone loss in rheumatoid arthritis be prevented?Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice.Physiological and pathophysiological bone turnover - role of the immune system.Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in mice.Cytokine and hormonal regulation of bone marrow immune cell Wnt10b expression.Suppressive Effect of the n-Hexane Extract of Litsea japonica Fruit Flesh on Monosodium-Iodoacetate-Induced Osteoarthritis in Rats.

P2860

Q24797889-9E60E166-BC61-4466-B911-E1CE31D9A389 Q24799036-319FE67C-CEEE-4C50-9F26-E63E8B92B7D5 Q28252713-029CC504-25ED-4D3A-83B4-A0815064ADB9 Q28570898-206E3A94-4266-45D4-B696-56660FC9C486 Q33554023-2FF6CFB8-69B3-4CAD-B476-C9D296944C56 Q33761069-7BBC306E-15FA-4D22-BF44-8E255DF85038 Q34001621-FE38B2CD-4D75-4086-8AE9-E9BC55D4F8E5 Q34497135-22D99FEB-1728-4FD6-AC92-01154A627721 Q35075554-47B64BC1-292C-4B1F-BF40-6AEE985ED3B2 Q35083436-0FB21EA3-6031-4F54-902E-5F31EBA6235E Q35643989-31630F5D-4F85-4847-B369-0DA5928BFCB9 Q35899487-8AE315A3-CBEC-4D34-A965-EA0314BC6A49 Q36078073-A93794D4-945F-44FF-AD09-98F85239A793 Q36204174-76D2F91C-56EA-451C-8AE2-E7DE63654528 Q36292663-0C2FBC1F-E5FE-48D0-978C-1B69E0B03FF8 Q36324975-C1F5F852-B669-40FC-9A75-1762100AE3CE Q36403383-960EC6D1-2A04-4464-ABB0-45A35643C582 Q36577375-5920DDF1-5455-41AA-B34B-26579A4E9FFA Q36600255-0AF3DE0E-9693-4CF5-8964-548291816ED1 Q36860987-2CD42251-41FE-427C-BD8E-DDBE67DFB4FD Q36932168-D69069F8-9F78-4E71-8FB3-A02982579ED6 Q36968961-72DF921A-5362-400F-88D2-44AA0B89456C Q37118786-97079599-B2A2-4624-9FC8-F0AC5D45C968 Q37206612-01B2324C-0446-48F5-9722-6084B71AE784 Q37287589-5F44D0AB-A135-4992-BDD4-1AB6697FC5AB Q37307805-EBAFF566-34D7-49B3-98D4-302951F8FE3B Q37316183-5A36A291-8EC9-4BBF-A368-CB9D98D02053 Q37627024-39605FF1-26E9-4EC8-A96F-549A76A278CE Q37765505-3DDA23DF-D25F-4447-AF27-1BB5D8D669B7 Q37801555-19408787-E89B-4B7A-BD81-326B43364642 Q37882064-6DBA5A19-CF48-4029-AD80-AA48FDD488CA Q38009712-2F8246E0-2A5C-4FCD-AC84-9888C9CFFC25 Q38114066-11996B66-E2B8-4F3E-B43D-6CF04925F5DC Q38115190-C2560C7C-9CDA-4CBE-A6D6-C08FA8678838 Q38593977-693AA56E-C1F1-4424-B4B9-CF218EE5C570 Q38852509-B11E6026-DBA6-43ED-9414-C0FFB21F93C0 Q38867785-029A456B-3D5C-49E7-B33B-1DE9ECB6BBC8 Q39085876-F189C850-B5B2-47CD-A8F6-77931FDD4127 Q41363594-8DDB02F5-71D2-4A89-827A-0E7B9636F096 Q41623255-2249162E-94BB-4973-9DDF-81EB821CC38B

P2860

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

http://www.wikidata.org/entity/Q47776871

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Osteoprotegerin protects again ...... crosis factor-transgenic mice.

@en

Osteoprotegerin protects again ...... crosis factor-transgenic mice.

@nl

type

label

Osteoprotegerin protects again ...... crosis factor-transgenic mice.

@en

Osteoprotegerin protects again ...... crosis factor-transgenic mice.

@nl

prefLabel

Osteoprotegerin protects again ...... crosis factor-transgenic mice.

@en

Osteoprotegerin protects again ...... crosis factor-transgenic mice.

@nl

P1433

Q47776871-6E54CF57-B3A9-4FDB-AFBA-FB0C8F22ED1D

P1476

Q47776871-A1560E92-C808-4960-9AE4-042C8FC19C48

P2093

Q47776871-1184C52F-1FAE-4ACC-B532-0E2F04B8D0F3

Q47776871-4EC9B0E1-73FB-47B6-8D77-AAC20A15911B

Q47776871-690C2802-E55A-4844-91AD-9BCBAC2CA3DD

Q47776871-BCD00BD3-E4CE-43BF-9FFE-31A9A5EFAD06

Q47776871-CE8114AF-869D-4B25-A0DE-63A34D5799CF

Q47776871-D049E016-92F7-4679-86A3-26AC51C8AD75

Q47776871-F2C4DFFF-A146-4B1C-8A8E-337390893991

P2860

Q47776871-2FE1A479-AC39-417E-9E4C-67937CA73588

Q47776871-325E36A6-38A7-46BC-A120-3DF4D0D8E682

Q47776871-54F95780-0404-4CEA-B32C-DF588BEE192B

Q47776871-5E94F4A1-35E1-487F-9055-B220294F61E8

Q47776871-5EDA8298-2A5B-4601-889C-C1C29ECCF049

Q47776871-65A88FFE-CF68-4CA4-88D3-8E1E1870B7F2

Q47776871-670AB5AF-BFD5-475D-9377-D52546E3C5C2

Q47776871-67123B07-264D-4A28-963F-5DA4B9E5D550

Q47776871-673362D3-6EF6-41F5-9262-9A298EEF574F

Q47776871-688D6B43-85E1-4AA2-9E1E-761D65D23D27

P304

Q47776871-919B6C0D-55DF-410B-B6FF-E192A65DB36C

P31

Q47776871-6B0E1C7B-C6AC-4C47-98B7-7AEE190ABEDE

P356

Q47776871-452D9FBF-4A72-4D57-A3E6-8354E2463207

P433

Q47776871-B7CFC843-1483-4DDA-954F-EFC8419A6424

P478

Q47776871-C970134B-8AD9-43C3-98FB-734C3956F6DB

P50

Q47776871-1BAA8BBF-D5C9-41D5-8844-0D0C6990B5FB

Q47776871-4A8A1D89-63A9-4D4C-A952-01611C2AECDC

Q47776871-7ADBFDBB-65A9-4456-85D7-79ABF9D97307

Q47776871-95505EF1-55F0-44ED-A528-7A9E06310246

Q47776871-970559DC-2A8D-4F01-AC26-42040E5CC26E

P577

Q47776871-42453D33-B863-47BE-AF2C-6D3631115DBC

P5875

Q47776871-15EBF08B-B4F3-4FC0-996F-E74A705555D3

P698

Q47776871-DCCEC9EC-836C-4C00-994B-9D216BB136EE

P356

P1433

Arthritis & Rheumatology

P1476

Osteoprotegerin protects again ...... crosis factor-transgenic mice.

@en

P2093

Andreas Schulz

http://www.w3.org/2001/XMLSchema#string

Birgit Görtz

http://www.w3.org/2001/XMLSchema#string

Brad Bolon

http://www.w3.org/2001/XMLSchema#string

Helga Bergmeister

http://www.w3.org/2001/XMLSchema#string

Jochen Zwerina

http://www.w3.org/2001/XMLSchema#string

Kurt Redlich

http://www.w3.org/2001/XMLSchema#string

Silvia Hayer

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Bone resorption by osteoclasts

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis.

Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?

Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis

The links between joint damage and disability in rheumatoid arthritis.

P304

2042-2051

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.11150

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Guenter Steiner

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10672597

http://www.w3.org/2001/XMLSchema#string

P698

12847699

http://www.w3.org/2001/XMLSchema#string